iGlyko. Inc.

Copyright ©, 2008-2010

iGlyko, Inc.

Dr. Sylvia Daunert

Scientific Advisor

Dr. Daunert is a Gill Eminent Professor of Analytical and Biological Chemistry, the 2004-2005 Distinguished Professor from the College of Arts & Sciences at the University of Kentucky, and a 2005-2006 University of Kentucky Research Professor. She is a Fulbright Scholar and the recipient of a Van Slyke Research Award from the American Association for Clinical Chemistry, a National Science Foundation-CAREER Award, a Cottrell-Scholars Award, a Lilly Analytical Faculty Award, the 2001 A.F. Findels Award from the American Chemical Society, a 2002 Special Creativity Award from the National Science Foundation, and 2004, 2005, 2006 Whetington Awards of the University of Kentucky.

Dr. Daunert's research interests lie in the area of Bioanalytical Chemistry, at the interface between Analytical Chemistry, Molecular Biology, and Bioengineering. She is Editor of Analytical and Bioanalytical Chemistry, Executive Editor of Analytical Biochemistry, and member of the editorial advisory boards of several other journals. Dr. Daunert has served on National Committees of the American Chemical Society since 1987 and in a number of other professional associations. Dr. Daunert is the author of close to 200 scientific articles and book chapters. She is also the editor of the book, "Photoproteins in Bioanalysis," and holds patents in the areas of genetically engineered proteins, biosensors, and responsive drug delivery.

Dr. Ping Wang

Scientific Advisor

Dr. Wang is Professor of Medicine and Director of the Diabetes Center at the University of California, Irvine and also serves as Chief of Endocrinology, Diabetes, and Metabolism at UCI Medical Center. Dr. Wang received his M.D. degree from Taiwan and Masters Degree from Harvard School of Public Health. After completing his residency training at Tufts University and Boston VA, Dr. Wang received endocrinology fellowship training at Harvard Medical School and the Joslin Diabetes Center.

He frequently lectures on the basic science and clinical issues of diabetes and metabolic syndrome in the U.S. and abroad. His research is focused on the mechanisms of diabetes and its related metabolic disorders and complications. Dr. Wang is a member of the study section on molecular signaling for the American Heart Association, and serves on the editorial board and expert review panels for leading medical and scientific journals. He has been selected as one of America's Top Doctors by Castle Connolly, and Best Doctors in America by BestDoctors, Inc.

Dr. Marc Madou

Scientific Advisor

Dr. Madou was the founder of the SRI International's Microsensor Department, founder and President of Teknekron Sensor Development Corporation (TSDC), Visiting Miller Professor at the University of California, Berkeley and Endowed Chair at Ohio State University (Professor in Chemistry and Materials Science and Engineering).

Before joining the University of California, Irvine as a Chancellor's Professor in Mechanical and Aerospace Engineering, Dr. Madou was Vice President of Advanced Technology at Nanogen in San Diego, California. He specializes in the application of miniaturization technology to chemical and biological problems, and is the author of several books in this burgeoning field which he helped pioneer both in academia and in industry. He completing the third edition of "Fundamentals of Microfabrication," which has become known as the "bible" of micromachining.

Dr. Jonathan Siegrist

Scientific Advisor

Dr. Siegrist earned his Ph.D. in the Department of Biomedical Engineering at UC Irvine. After obtaining his Master's Degree from the same department, he joined Dr. Marc Madou's group for research involving centrifugal microfluidic platforms for nucleic acid analysis. This included the design, fabrication, and testing of platforms for applications such as real-time analysis of Anthrax and microarray scanning for respiratory virus diagnostics.

Before attending UC Irvine, Dr. Siegrist obtained his Bachelor's Degree in Electrical Engineering from UCLA. His undergraduate research at UCLA involved MEMS-based deep-brain stimulation probes for Parkinson's disease. Other R&D experiences include work in the Bioengineering Department of the Lawrence Berkeley National Lab and in the biochemistry group at Gen-Probe, Inc.

Mr. Dean Yoost

Business Advisor

Mr. Yoost retired as a partner after 32 years with PriceWaterhouseCoopers, where he held numerous leadership positions. He is currently a member of the Board of Directors of Pacific Life, a Fortune 500 company and California's largest life insurer. He is also a board member of Emulex Corporation, a NYSE-listed company and a leading source of advanced storage networking infrastructure solutions, and a board member and Chairman of the Risk Management Committee of Union Bank of California, a NYSE-listed bank that ranks among the largest 25 banks in the U.S. Additionally, Mr. Yoost is a trustee of the UCI Foundation, and Chairman of the Executive Board of UCI's Joslin Diabetes Leadership Council. Mr. Yoost is a certified public accountant and holds two masters' degrees in business and taxation.